Ignore The Noise - Novo Nordisk Is A Clear Buy

In my last article about Novo Nordisk ( NVO ) I wrote, that the stock has probably declined enough. I already rated the stock as a "Buy" but the stock continued to decline, and it is now trading about 23% lower compared to FebruaryMy analysis is focused on high-quality companies, that can outperform the market over the long-run due to a competitive advantage (economic moat) and high levels of defensibility. Focused on European and North American companies, but without constraints regarding market capitaliza ...